Parkinson's disease--the debate on the clinical phenomenology, aetiology, pathology and pathogenesis
about
Melatonin and Other Tryptophan Metabolites Produced by Yeasts: Implications in Cardiovascular and Neurodegenerative DiseasesSex differences in Parkinson's diseaseRole of α- and β-Synucleins in the Axonal Pathology of Parkinson's Disease and Related SynucleinopathiesLithium protects against paraquat neurotoxicity by NRF2 activation and miR-34a inhibition in SH-SY5Y cells.Total and Proteinase K-Resistant α-Synuclein Levels in Erythrocytes, Determined by their Ability to Bind Phospholipids, Associate with Parkinson's Disease.Interaction between Neuromelanin and Alpha-Synuclein in Parkinson's Disease.Comparing Alzheimer's and Parkinson's diseases networks using graph communities structureRole for the microtubule-associated protein tau variant p.A152T in risk of α-synucleinopathies.Neuropathological Staging of Brain Pathology in Sporadic Parkinson's disease: Separating the Wheat from the Chaff.The Synucleinopathies: Twenty Years On.Metallothionein, Copper and Alpha-Synuclein in Alpha-Synucleinopathies.Initial elevations in glutamate and dopamine neurotransmission decline with age, as does exploratory behavior, in LRRK2 G2019S knock-in miceMutations in the Parkinson's Disease-Associated PARK2 Gene Are Accompanied by Imbalance in Programmed Cell Death Systems.Neurodegeneration and the ordered assembly of α-synuclein.Diagnostic Criteria for Parkinson's Disease: From James Parkinson to the Concept of Prodromal Disease.Role of Ionizing Radiation in Neurodegenerative Diseases.Tau Pathology in Parkinson's Disease
P2860
Q26772733-EAEED372-B547-476B-A8D7-6609B32028BFQ27025107-8C8FBF59-AF0C-4D6E-BC40-0E7B3CF5BE50Q28083418-3E3F3792-CBF9-4E16-A5EA-B732949F5E00Q35657214-C613FBC9-E1A4-43D7-9A3E-CE4ED725527DQ35726772-6CE749A1-BAE9-4CC6-8B11-6669D687C550Q35834043-0F2FBE0A-597A-4E61-AC2D-6774B7F33F13Q35943528-C021485D-FCE1-4A4B-A00F-E722816FE97FQ36300071-B62BE89F-4773-4A87-8107-4E1E3AA17433Q37693339-B304343F-E728-48E3-94B0-E32231DAEBF4Q37693375-351DF1DF-4B40-4B5D-A71C-5CF90CB4E0D5Q37737068-A406FE45-3EC3-40E9-ADDB-123E8061D961Q42268862-B46FEF23-6267-408D-8D72-884853CBE0C8Q43082776-3C6FC469-367D-4646-BCA4-68BDCD49A093Q50101026-1AF3E843-A861-4BF5-9CC3-A24E4B3891D6Q52599693-C93EB129-452C-4C4C-BB17-2F562EEEF795Q55112653-E7E3301F-BF91-4BBA-9495-3E8CEF6B1C45Q58586744-A4B84770-8315-41D4-A77D-1CA847C2C6AA
P2860
Parkinson's disease--the debate on the clinical phenomenology, aetiology, pathology and pathogenesis
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Parkinson's disease--the debat ...... gy, pathology and pathogenesis
@en
type
label
Parkinson's disease--the debat ...... gy, pathology and pathogenesis
@en
prefLabel
Parkinson's disease--the debat ...... gy, pathology and pathogenesis
@en
P2093
P2860
P50
P921
P356
P1476
Parkinson's disease--the debat ...... gy, pathology and pathogenesis
@en
P2093
John V Hindle
Michel Goedert
Paul Bolam
Peter Jenner
P2860
P356
10.3233/JPD-130175
P5008
P577
2013-01-01T00:00:00Z